BTF3P11 |
|
basic transcription factor 3 pseudogene 11
|
|
|
0.519 |
0.731 |
HLA-DRB9 |
|
major histocompatibility complex, class II, DR beta 9 (pseudogene)
|
|
|
0.682 |
0.654 |
HLA-L |
|
major histocompatibility complex, class I, L (pseudogene)
|
|
|
0.861 |
0.269 |
IFN1@ |
|
interferon, type 1, cluster
|
|
|
0.565 |
0.731 |
NM |
|
neutrophil migration
|
|
|
0.473 |
0.808 |
PVT1 |
|
Pvt1 oncogene
|
|
|
0.495 |
0.731 |
TRBV20OR9-2 |
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
|
0.403 |
0.923 |
CDR3 |
|
Cerebellar degeneration-related autoantigen-3
|
|
|
0.472 |
0.808 |
HCG9 |
|
HLA complex group 9
|
|
|
0.700 |
0.500 |
IGHV3OR16-7 |
|
immunoglobulin heavy variable 3/OR16-7 (pseudogene)
|
|
|
0.566 |
0.654 |
IGHV3-69-1 |
|
immunoglobulin heavy variable 3-69-1 (pseudogene)
|
|
|
0.561 |
0.654 |
MBL3P |
|
mannose-binding lectin family member 3, pseudogene
|
|
|
0.518 |
0.769 |
GAS5 |
|
growth arrest specific 5
|
|
|
0.497 |
0.808 |
ERVK-6 |
|
endogenous retrovirus group K member 6, envelope
|
|
|
0.521 |
0.808 |
HT |
|
Hashimoto thyroiditis
|
|
|
0.505 |
0.731 |
H3P44 |
|
H3 histone pseudogene 44
|
|
|
0.636 |
0.462 |
LINC01193 |
|
long intergenic non-protein coding RNA 1193
|
|
|
0.565 |
0.692 |
LINC00243 |
|
long intergenic non-protein coding RNA 243
|
|
|
0.729 |
0.423 |
TRIM26BP |
|
tripartite motif containing 26B, pseudogene
|
|
|
0.861 |
0.269 |
MIR125A |
|
microRNA 125a
|
|
|
0.480 |
0.769 |
MIR126 |
|
microRNA 126
|
|
|
0.447 |
0.846 |
MIR142 |
|
microRNA 142
|
|
|
0.480 |
0.846 |
MIR145 |
|
microRNA 145
|
|
|
0.431 |
0.846 |
MIR146A |
|
microRNA 146a
|
|
|
0.398 |
0.885 |
MIR148A |
|
microRNA 148a
|
|
|
0.506 |
0.846 |